Paris ALS Center

Hôpital de la Salpêtrière

The Paris ALS Center was created by Pr Vincent Meininger. It is devoted to the diagnosis and care of patients with ALS and other motor neuron diseases.

Hôpital de la Salpêtrière

To understand the disease mechanisms at work in ALS, our first objective was to perform clinical research and study the natural disease course of ALS. This strategy led to the first successful clinical trial in 1994. Beside our current involvement with clinical trials, we acquired an expertise in muscle biomarkers, genetics and neuroimaging.

Contact
Location
Hôpital de la Salpêtrière, Boulevard de l'Hopital, Paris, France

Our Specialists

François Salachas

Coordinator and Investigator of research

Dr. François Salachas is Coordinator and Investigator of research in Hôpital Pitié-Salpêtrière.

François Salachas
Current trials
Recruiting
Phase iii

COURAGE-ALS Trial

Industry trial

In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS. This clinical trial is sponsored by Cytokinetics.

Read more
Recruiting
Phase iii

PHOENIX trial

Industry trial

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound ‘AMX0035’ for the treatment of ALS.

Read more
Active
Phase iii

ADORE trial

Industry trial

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).

Read more